Pfizer Inc. PFE NYSE

Pfizer Inc. (PFE) reported total assets of $208.16B and total liabilities of $121.39B for fiscal year 2025, resulting in total equity of $86.78B.

The company held $13.6B in cash and short-term investments. Total debt stood at $67.42B, with net debt of $66.27B. The Debt-to-Equity (D/E) ratio was 0.78 (moderate).

Current ratio is 1.16, suggesting adequate short-term liquidity. Interest coverage is 5.8x (adequate).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (94/100) — Total assets $208.16B and equity $86.78B support the company's competitive scale
• VALUE (61/100) — Debt-to-Equity 0.78 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%

MRK

Merck & Co., Inc.

$119.96

-0.16%

AMGN

Amgen Inc.

$350.95

+0.32%

NVO

Novo Nordisk A/S

$39.32

+3.53%

GILD

Gilead Sciences, Inc.

$140.45

+1.02%

DHR

Danaher Corporation

$198.61

+1.40%